Think of it as money's superpower: Small contributions today can snowball into life-changing sums decades down the road. That ...

For investors, the most decisive edge is not stock-picking brilliance or perfect market calls, it is the quiet arithmetic of time. When returns are allowed to build on themselves for long stretches, ...

When you have to go on a medication, your doctor will probably prescribe a premade one that's FDA-approved. But sometimes, they may want you to go on a compounded medicine that's specifically made for ...

Demand for popular weight loss drugs such as semaglutide (Wegovy) and tirzepatide (Zepbound) has long outpaced supply, forcing many patients with obesity to visit compounding pharmacies to get ...

Outraged over a 2012 fungal meningitis outbreak traced back to Framingham, Massachusetts-based drug compounder New England Compounding Center (NECC) that left sixty-four people dead and more than 700 ...

In early 2024, the American Society of Health-System Pharmacists (ASHP) reported a record 323 active drug shortages, many affecting sterile injectable medications. This situation was exacerbated later ...

The FDA’s approval of the drug Aduhelm as a treatment for Alzheimer’s disease — despite the recommendation of its own advisory committee against approval — came as a surprise to many. But to me, that ...

Michael Boyle is an experienced financial professional with more than 10 years working with financial planning, derivatives, equities, fixed income, project management, and analytics. Suzanne is a ...

If your AI investment needs constant justification, it’s already in trouble. One-time productivity bumps don’t move margins. Demos don’t survive budget reviews. And “AI adoption”...Read More The post ...

Barry Cadden, the former owner of a Massachusetts compounding pharmacy linked to a deadly 2012 multistate fungal meningitis outbreak, pleaded no contest Monday to 11 counts of involuntary manslaughter ...